Drug Discovery Technology TechVision Opportunity Engine

The Drug Discovery Technology (DDT) Alert is Technical Insights' new technology research subscription that reports and analyzes the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain.

Title Published
Innovations in Precision and Regenerative Medicine - Drug Discovery TOE 13 May 2016
Novel Drug Delivery Systems in the Spotlight-Drug Discovery Alert 08 Apr 2016
Big Data in Drug Discovery Digging beyond the Internet of Things-Drug Discovery Alert 11 Mar 2016
Drug Discovery Technology--Trends in Colorectal Cancer Therapeutics 12 Feb 2016
Drug Discovery Technology--Drug Discovery and Biomanufacturing Technology for Drug Delivery, across Cancer, Autoimmune Diseases, and Rare Disorders 08 Jan 2016
Drug Discovery Technology TechVision Opportunity Engine. Hematologic Stem Cell Transplantation Enhancement Aiming to Reduce Graft Versus Host Disease; Novel Medication for the Treatment of Hypophosphatasia Becomes Available 11 Dec 2015
Drug Discovery Technology TechVision Opportunity Engine. 3D Nano-Engineered Construct for Early Stage Drug Discovery and Development in Neurological Disorders 13 Nov 2015
Drug Discovery Technology Alert. Reprogramming Pancreatic Alpha-Cells into Functional Beta-Cells as a Cell-Replacement-Based Therapy for Diabetes; Novel Drug Treatment for Orotic Aciduria Receives FDA Approval; Drug To Treat Chronic Heart Failure 09 Oct 2015
Drug Discovery Technology Alert. Immunotherapies Leading the Convergence of Technologies in the Healthcare Sector 11 Sep 2015
Drug Discovery Technology Alert. Building Enhanced Antibody-Protein Fusion Molecules for Immuno-Oncology Applications; Advancing Prophylactic and Therapeutic Vaccines for Cancer 14 Aug 2015

About this service

Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..